Crossmark

Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies

Crossref DOI link: https://doi.org/10.1038/s41409-019-0726-7

Published Online: 2019-10-31

Published Print: 2020-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peric, Zinaida

Mohty, Razan

Bastos, Juliana

Brissot, Eolia

Battipaglia, Giorgia http://orcid.org/0000-0002-5201-1786
Belhocine, Ramdane

Sestili, Simona

Giannotti, Federica

Vekhoff, Anne

Ledraa, Tounes

Legrand, Ollivier

Lapusan, Simona

Isnard, Francoise

Labopin, Myriam

Bonnin, Agnes

Mediavilla, Clemence

Rubio, Marie-Thérèse

Ruggeri, Annalisa

Duléry, Rémy

Malard, Florent http://orcid.org/0000-0002-3474-0002
Mohty, Mohamad
License Information

Text and Data Mining valid from 2019-10-31

Version of Record valid from 2019-10-31
More Information

Article History

Received: 30 December 2018

Revised: 28 July 2019

Accepted: 10 August 2019

First Online: 31 October 2019

Compliance with ethical standards

:

: MM, RD, FM, and MTR have received honoraria for lectures from Keocyt, whose drug was included in this study. MM received honoraria for lectures from Sanofi, whose drug was included in this study. The other authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below